Exploration of Targeted Anti-tumor Therapy

Exploration of Targeted Anti-tumor Therapy | Open Exploration    📚 Popular New Cited #Review sharing! Happy reading!   📄 Titled "Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment".   👨🏫 This insightful piece by Eric J. * et al.   🔖 This review provides a detailed overview of the current understandings behind the mechanisms of MDSC-mediated suppression of anti-tumour immunity, and discusses potential strategies to target MDSC immunosuppressive mechanisms to overcome therapeutic resistance.   🗺️ This article belongs to the special issue Novel Strategies and Targets for #Immunotherapy of #Cancer    📍 Access the full text at: https://lnkd.in/ghyMsQmV    💯 Don't miss out on this exciting opportunity to expand your knowledge and stay up-to-date with the latest developments    ❗ Happy reading!   #TumorMicroenvironment, #CancerTherapy, #PreclinicalModels, #Immunotherapy, #MyeloidDerivedSuppressorCell, #MyeloidCells, #Immunosuppression

Exploration of Targeted Anti-tumor Therapy | Open Exploration 📚 Popular New Cited #Review sharing! Happy reading! 📄 Titled "Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapy". 👨🏫 This insightful piece by Charupong Saengboonmee * et al. 🔖 This article reviews the roles, potential, and challenges of using MNPs in advancing cancer immunotherapy. The application of MNPs in boosting immunotherapy, and its perspective role in research and development is also discussed. 🗺️ This article belongs to the #SpecialIssue Novel Strategies and Targets for Immunotherapy of Cancer 📍 Access the full text at: https://lnkd.in/gYiRCkwd 💯 Don't miss out on this exciting opportunity to expand your knowledge and stay up-to-date with the latest developments. ❗ Happy reading! #Cancer, #MagneticIronOxideNanoparticles, #Immunotherapy, #TumorMicroenvironment

😆 Exciting news! ---    📚 Popular Cited #Review sharing! Happy reading!    📄 Titled "Recent preclinical and clinical advances in #radioimmunotherapy for non-Hodgkin’s #lymphoma".    👨🏫 This insightful piece by Hiroki Goto*, Yoshioki Shiraishi, Seiji Okada    🔖 This review summarizes the recent preclinical and clinical advances in RIT for treating NHL and discuss future applications of RIT and radiotheragnostic agents.    📍 Access the full text at: https://lnkd.in/gPF54i8H    🔓 The PDF version is also available for download: https://lnkd.in/g2dTCNGG    💯 Don't miss out on this exciting opportunity to expand your knowledge and stay up-to-date with the latest developments.    ❗ Happy reading!   #Radioimmunotherapy #MonoclonalAntibody #non-Hodgkin’s #lymphoma, #PreTargeted #radioimmunotherapy, #ImmunoPositronEmission #tomography

How are you today? Tell us what you want to hear from us. If you want to stay up-to-date with us, follow our Page.

Exploration of Targeted Anti-tumor Therapy | Open Exploration 💥【Heat #SpecialIssue】 ➡ Emerging Molecular Targets and Therapies of #GenitourinaryTumors Keywords: #GenitourinaryCancer, #MolecularOncology, #TargetedTherapy, #CancerGenomics, #ImmuneResponse, #DiseaseProgression, #TreatmentResistance 👨🏫 Guest Editors: Dr. Alcides Chaux 🔗 https://lnkd.in/g84kZW_v 📢 【Parts of Heat papers】 ➡ Diagnostic and prognostic role of NLR in testicular cancer #Neutrophil to lymphocyte ratio, #TesticularCancer, #SystematicReview https://lnkd.in/gu92VVhs ➡Emerging molecular therapies in the treatment of #BladderCancer #BladderCancer, #MolecularTherapy, #CancerTherapy https://lnkd.in/gE9WCVy4 ➡The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC) #Cisplatin-eligible, #AvelumabMaintenance, #EnfortumabVedotin, #pembrolizumab, #nivolumab https://lnkd.in/gvYNtfEE ➡Landscape of targeted therapies for advanced urothelial carcinoma #Bladdercancer, advanced urothelial carcinoma, targeted therapy, #CombinationTherapy, #MolecularAlteration https://lnkd.in/g9trbQrW 👻 Happy reading!

😆 New #Review sharing! Happy reading! 🔎 Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer. 📖 This review outlines the literature of neoadjuvant and perioperative immunotherapy and discusses its potential benefits and complexities and ongoing considerations into future research. 🎉 Authors: Udit Nindra * et al. 🎈 Academic Editor: Professor Stergios Boussios, King’s College London, UK 📚 This article belongs to the #SpecialIssue Immunotherapy Strategies for Non-small Cell Lung Cancer 😆 Welcome to read, forward, and share the article! 🔗 https://lnkd.in/g8EBJR8n #Chemoimmunotherapy, #ResectableNSCLC, #PathologicalCompleteResponse, #OverallSurvival, #Surgery

😆 New #Review sharing! Happy reading! 🔎 Exploring the therapeutic potential of lipid-based #nanoparticles in the management of oral squamous cell carcinoma 📖 This review aims to discuss current treatment approaches and their limitations, as well as recent advancements in LNPs for better management of OSCC. 🎉 Authors: Md. Rizwanullah, Ph.D. * et al. 😆 Welcome to read, forward, and share the article! 🔗https://lnkd.in/gheqXtvN #OralSquamousCellCarcinoma, #Pathogenesis #LipidBasedNanoparticles, #PassiveTargeting, #ActiveTargeting, #cytotoxicity

Exploration of Targeted Anti-tumor Therapy | Open Exploration 😀 Are you a researcher or professional in the field of #InorganicNanomaterials or #CancerTherapy? Check out this exciting opportunity to contribute to the latest special issue of ETAT journal on Potential #ClinicalApplications of #InorganicNanomaterials in Cancer This Special Issue aims to advance the following areas: #Synthesis: improved methods for single or multicomponent inorganic nanoparticles, with high control in their morphology, uniformity, surface functionalization, and properties. Those nanoparticles should be aimed at cancer therapies, especially relevant are those that can combine different therapies for synergistic treatments or can combine therapies + diagnosis approaches. #Characterization: progress in physicochemical characterization methods that improve our understanding of how those nanoparticles work in a cancer therapy or diagnosis. #Application: Studies on the performance of those nanoparticles in cancer treatment and diagnosis including in vitro and in vivo studies, applications in 3D models, biokinetics of tumor accumulation, detection of microtumors, etc. 👨🏫 guest edited by Prof. Javier Reguera (University of Valladolid) 👨🏫As a contributor, you can benefit from hashtag #PubMed/PMC, #GoogleScholar, #Scopus, and #DOAJ indexing, open access publication, and no Article Processing Charges. Plus, authors retain copyright, and the research is widely promoted. 😉 If you have valuable insights or research to share on #InorganicNanomaterials and #CancerTherapy, consider submitting your work. 😉Don't miss the chance to be recognized through the #MostCitedPaperAward annually. 👉 For more information and submission details, visit: https://lnkd.in/gmWz_5eE ❓ Got any ideas or questions? Feel free to reach out. Your contribution is warmly welcomed!

✨ **Global Call for #OriginalArticles** ✨ 🥇 In today's rapidly evolving healthcare landscape, ETAT is excited to embark on a worldwide quest for the submission of Original Articles, driven by our internal aspirations and developmental roadmap. We cordially invite you to participate in this thrilling call for contributions. 🎯 Whether you are working on groundbreaking research in cancer-targeted therapies, innovative clinical applications, or insightful depth analyses, every piece has the potential to capture our attention and shape the future of our publication.   ❓ Why Participate US? ✅ No APCs throughout the entire process---alleviating the burden of APCs on academic contributions. ✅ All published articles can be indexed and retrieved in PMC/PubMed, Scopus, and Google Scholar--- making the exposure, readership, and citation of the articles remarkably increasing. ✅ Published articles are open access and the copyright remains with the authors---promoting widespread dissemination of the articles and enabling more interested individuals to read your work. ✅ Annual "#MostCitedPaperAward" (300-1000USD) ---which serves as a reward for authors of high-quality articles cited five or more times. 🗝 Let’s push the boundaries of medical science together! We look forward to your exciting contributions. ⚠ If you have any questions or need more information, please feel free to reach out. Find more at: https://lnkd.in/ff2NJqa #ETAT #OriginalArticles #CancerResearch #MedicalInnovation #ScientificCommunication #NoAPCs

Exploration of Targeted Anti-tumor Therapy | Open Exploration 💥【Heat #SpecialIssue】 ➡ Emerging Molecular Targets and Therapies of #GenitourinaryTumors Keywords: #GenitourinaryCancer, #MolecularOncology, #TargetedTherapy, #CancerGenomics, #ImmuneResponse, #DiseaseProgression, #TreatmentResistance 👨🏫 Guest Editors: Dr. Alcides Chaux 🔗 https://lnkd.in/g84kZW_v 📢 【Parts of Heat papers】 ➡ Diagnostic and prognostic role of NLR in testicular cancer #Neutrophil to lymphocyte ratio, #TesticularCancer, #SystematicReview https://lnkd.in/gu92VVhs ➡Emerging molecular therapies in the treatment of #BladderCancer #BladderCancer, #MolecularTherapy, #CancerTherapy https://lnkd.in/gE9WCVy4 ➡The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC) #Cisplatin-eligible, #AvelumabMaintenance, #EnfortumabVedotin, #pembrolizumab, #nivolumab https://lnkd.in/gvYNtfEE ➡Landscape of targeted therapies for advanced urothelial carcinoma #Bladdercancer, advanced urothelial carcinoma, targeted therapy, #CombinationTherapy, #MolecularAlteration https://lnkd.in/g9trbQrW 👻 Happy reading!